Korea Medical Aesthetics Market: Market Size & Forecast 2026

Korea's medical aesthetics market sits within the larger Asia Pacific region, which is one of the fastest-growing medical aesthetics markets globally due to high procedure volumes and strong cultural emphasis on appearance. The market is forecast to continue expanding at roughly 12.8% annually, supported by a mature network of dermatology and plastic surgery clinics and rising consumer spending on advanced skin treatments. Facial rejuvenation procedures in particular have shown significant volume growth over the past decade, reinforcing Korea's position as both a leading consumer market and a global hub for aesthetic medical tourism.

• •Valued at about $19.36 billion in 2025 with projected annual growth near 12.8%
• •Procedural volumes and per-capita spending are among the highest in Asia Pacific
• •Facial rejuvenation and minimally invasive treatments are the dominant categories

Demand is being lifted by a strong cultural focus on skincare, a large base of younger consumers, and growing acceptance of aesthetic procedures among men and women. Medical tourism, particularly from neighboring Asian countries, adds significant inbound revenue and supports premium service offerings. Technological advances in injectables, energy-based devices, and regenerative formulations, alongside favorable regulatory oversight by the Ministry of Food and Drug Safety, continue to accelerate adoption.

• •Rising consumer spending on cosmetics and beauty across Asia Pacific economies
• •Expanding medical tourism as Korea becomes a regional hub for aesthetic procedures
• •Innovation in dermal fillers, neurotoxins, and regenerative aesthetic therapies

The market spans surgical procedures, non-surgical injectables and fillers, energy-based devices, regenerative and stem-cell-based therapies, and topical cosmeceuticals. Within Korea, Seoul's Gangnam district remains the most concentrated cluster of aesthetic clinics, while secondary cities such as Busan, Incheon, and Daegu are emerging growth corridors. The Asia Pacific region overall is projected to outpace global averages in compound growth through 2030, driven by expanding middle-class populations in Korea, China, and Southeast Asia.

• •Injectables and energy-based devices represent the largest and fastest-growing sub-segments
• •Seoul dominates clinic density, with secondary cities gaining market share
• •Asia Pacific is the highest-growth region globally through 2030 forecasts

What are the recent trends and outlook?

Looking ahead, the Korean market is expected to benefit from rising demand for personalized treatments, AI-assisted aesthetic planning, and regenerative therapies such as exosome- and polynucleotide-based skin rejuvenation. Consumers are increasingly seeking minimally invasive procedures with shorter recovery times, encouraging further investment in next-generation fillers, biostimulators, and energy-based platforms. Korea's combination of regulatory rigor, clinical expertise, and consumer sophistication positions it to remain a leading innovation and export hub for medical aesthetics through 2030.

• •Regenerative aesthetics, including exosome-based and polynucleotide treatments, is an emerging growth area
• •AI-driven forecasting tools are increasingly used to project procedure demand and personalize treatment plans
• •Demand for minimally invasive procedures with reduced downtime continues to reshape the service mix